The discussion “Hormone therapy associated with the risk of Breast cancer” is very hot now days. Hormone Replacement Therapy which is being used to treat menopause symptoms is been associated with the breast cancer risks for the last months. But a recent research has indicated a different theory against this.

Yale researchers report in an abstract presented at the American Society for Reproductive Medicine (ASRM) scientific meeting in Atlanta, Georgia, October 17-21 that;

“The right combination of estrogen and a selective estrogen receptor modulator (SERM), which blocks the effects of estrogen in breast tissue, could relieve menopause symptoms and cut breast cancer risk.”